Also, during this phase, epigenetic mechanisms lead to a process of histone hypomethylation and acetylation that favors the expression of HLA-G, which competes with the antigenic presentation by classical histocompatibility molecules, promoting a process of tumor tolerance (Figure 4B). Here, HLA-G is linked to neoplasm.